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Type II spiral ganglion afferent neurons drive medial
olivocochlear reflex suppression of the cochlear
amplifier
Kristina E. Froud1, Ann Chi Yan Wong1,4, Jennie M. E. Cederholm1, Matthias Klugmann1, Shaun L. Sandow1,2,
Jean-Pierre Julien3, Allen F. Ryan4 & Gary D. Housley1
The dynamic adjustment of hearing sensitivity and frequency selectivity is mediated by the
medial olivocochlear efferent reflex, which suppresses the gain of the ‘cochlear amplifier’ in
each ear. Such efferent feedback is important for promoting discrimination of sounds in
background noise, sound localization and protecting the cochleae from acoustic over-
stimulation. However, the sensory driver for the olivocochlear reflex is unknown. Here, we
resolve this longstanding question using a mouse model null for the gene encoding the type III
intermediate filament peripherin (Prph). Prph( / ) mice lacked type II spiral ganglion neuron
innervation of the outer hair cells, whereas innervation of the inner hair cells by type I spiral
ganglion neurons was normal. Compared with Prph(þ /þ ) controls, both contralateral and
ipsilateral olivocochlear efferent-mediated suppression of the cochlear amplifier were absent
in Prph( / ) mice, demonstrating that outer hair cells and their type II afferents constitute
the sensory drive for the olivocochlear efferent reflex.
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H
earing performance is dependent upon the active
enhancement of sound-induced vibration of the cochlear
organ of Corti through prestin-mediated outer hair cell
(OHC) electromotility1. The action of this ‘cochlear amplifier’2,3 is
responsible for the sensitivity and exquisite frequency resolution
of mammalian hearing and can be assessed by measuring
distortion product otoacoustic emissions (DPOAEs)4,5 in the ear
canal. The cochlear amplifier selectively amplifies cochlear
vibrations in a focused region of the cochlea, thereby enhancing
sound transduction at inner hair cells (IHCs), each of which
receives exclusive sensory innervation from several type I spiral
ganglion neurons (SGNs), whose central projection to the
brainstem cochlear nuclei drives hearing perception. The relative
levels of sound transduced by IHCs between the two ears is
principally regulated by a sensorimotor reflex pathway, which
responds to elevation of sound in one ear by rapidly reducing the
gain of the cochlear amplifier in the opposite cochlea5–7. This
‘contralateral suppression’ is produced by medial olivocochlear
(MOC) efferent neurons located in the superior olivary complex of
the brainstem, whose myelinated axons approach the floor of the
fourth ventricle from both sides before migrating laterally to join
the ipsilateral auditory nerve and terminate on the OHCs8. These
cholinergic MOC synapses hyperpolarize the OHCs, inhibiting
OHC electromotility and thus reducing the gain of the cochlear
amplifier9–12. In addition to contralateral suppression, there is also
an ipsilateral pathway through which MOC neurons suppress the
cochlear amplifier7,13. Efferent control of the cochlear amplifier
has been shown to be necessary for speech discrimination in
noise14,15, sound localization16 and protection from noise-induced
hearing loss17. However, the sensory input that drives this
neural control process has not been identified8.
The cochlear amplifier gain control reflex must either originate
with primary auditory encoding of the sound perception channel
by type I SGN, which make up 95% of the spiral ganglion, and/or
with the residual 5% of the SGNs—designated type II, which
exhibit a dispersed sensory innervation of OHCs18–26. The
function of the type II SGN remains enigmatic8. Here, we assess
the role of type I versus type II SGNs in the MOC reflex by
utilizing a mouse model, null for gene encoding the type III
intermediate filament peripherin (Prph( / )), that is found to
lack type II SGN innervation of OHCs. Absence of suppression of
the cochlear amplifier-derived DPOAEs in response to
contralateral or ipsilateral sound in these Prph( / ) mice
supports the hypothesis that the putative OHC—type II SGN
sensory transmission drives the MOC efferent regulation of
cochlear amplifier gain. Thus, MOC reflex control of hearing
sensitivity utilizes a closed-loop negative-feedback pathway with
the OHCs operating as both the sensor and effector.
Results
Prph( / ) mice lack type II SGN innervation. In the mouse
cochlea, peripherin (PRPH) is exclusive to the type II SGNs
during the establishment and maturation of the OHC innerva-
tion27–30. We examined cochlear innervation patterns in an
established Prph( / ) mouse line31 and found complete absence
of OHC innervation by unmyelinated type II SGN neurites,
consistent with key roles for PRPH in the regulation of peripheral
sensory fibre extension and maintenance28,32–34. The Prph( / )
mouse line was initially characterized as lacking a substantial
proportion of unmyelinated sensory fibres from the L5 dorsal
root ganglion31, which prompted our assessment of this model to
investigate the physiological significance of the unmyelinated
cochlear type II SGN sensory fibres.
The type II SGN innervation of the OHCs was identified using
PRPH immunofluorescence in cochlear cryosections and surface
mounts of the Prph(þ /þ ) organ of Corti from postnatal day 4
(Supplementary Fig. 1). The PRPH-positive type II SGN neurites
extend from the somata in Rosenthal’s canal, past the type I SGN
(radial fibre) innervation of the IHCs at the inner spiral plexus,
crossing the floor of the tunnel of Corti. The type II SGN fibres
then turn basally at the Deiters’ cell level to form the outer spiral
bundle (OSB) that innervates multiple OHCs19,22. This was most
evident in the neonatal cochlea (Supplementary Fig. 1a,c–f),
whereas PRPH immunolabelling in the adult cochlear type II
SGN fibres diminished beyond the inner spiral plexus
(Supplementary Fig. 1b,g,h), compared with resolution of the
OSB with neurofilament 200 kDa (NF200) immunolabelling
(Fig. 1a,c). The absence of PRPH in the Prph( / ) spiral
ganglion was confirmed (Supplementary Fig. 1b right inset).
The NF200 also resolved MOC efferent fibres, while co-
immunolabelling with vesicular acetylcholine transporter
(VAChT; ref. 17) showed the extension of the MOC fibres to
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Figure 1 | Loss of afferent innervation of outer hair cells (OHC) in
Prph( / ) cochlea. (a) Type II spiral ganglion neuron (SGN) outer spiral
bundle (OSB) innervation of the OHC runs alongside the Deiters’ cells (DC)
and is resolved in adult Prph(þ /þ ) organ of Corti via neurofilament
200 kDa immunofluorescence (red). This immunolabelling (confocal
optical slice with transmitted light overlay) of a cryosection (50 mm)
through the organ of Corti also identifies the medial olivocochlear (MOC)
efferent fibres crossing the tunnel of Corti to innervate the OHC. CtBP2
immunofluorescence (green puncta) labels the presynaptic ribbons at the
base of the OHC nuclei and at the inner spiral plexus (ISP) region of the
inner hair cell (IHC) (the IHC nucleus is also labelled by this antibody).
Blue fluorescence is DAPI nuclear staining. OSL, osseous spiral lamina.
(b) Neurofilament 200 kDa immunofluorescence image of adult Prph( / )
organ of Corti in a cryosection, as for a, showing the absence of the type II
SGN innervation of the OHC via the OSB. (c) The type II SGN OSB fibres
were more fully resolved in the adult Prph(þ /þ ) organ of Corti mid-
cochlear level whole mount via the neurofilament immunofluoresence
(three-dimensional reconstruction of optical slices imaged from the basilar
membrane; colour coded for depth (z)). Multiple fibres are shown crossing
the floor of the tunnel of Corti, to enter the OSB and turn basally in parallel
tracks (arrow). Deeper in the tissue, the MOC efferent fibres project to the
OHC, terminating with bulbous synaptic boutons (VAChT immunolabelling;
green–blue). (d) OSB fibres were absent in the adult Prph( / ) organ of
Corti (crossed arrow); whole mount as for c. Note the retention of the MOC
innervation to the OHC.
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clusters of efferent boutons at the base of the OHCs (Fig. 1a–d
and Supplementary Movies 1 and 2).
The OSB was absent in the Prph( / ) organ of Corti
(Fig. 1b,d), a few residual type II SGN fibres were occasionally
observed extending toward the OHCs, although none are
visible in the fields shown here. In contrast, the MOC
efferent innervation of the OHCs was preserved (Fig. 1b,d and
Supplementary Movie 2). The loss of the OSB in the
Prph( / ) cochleae was confirmed in eight adult mice, alongside
well-resolved OSBs imaged in cochleae from five Prph(þ /þ )
and one Prph(þ / ) animal, using NF200 immunofluorescence.
Thus knockout of Prph expression selectively disrupted the type
II SGN afferent innervation of the OHCs.
Serial block face imaging in the (field emission) scanning
electron microscope (SBF-SEM) resolved the small type II SGN
afferent synaptic boutons adjacent to the large MOC efferent
boutons at the base of the Prph(þ /þ ) OHCs in the mid-apical
turn region of the cochlea (Supplementary Fig. 2a,c,d,g). No
type II SGN synaptic boutons were identified in Prph( / )
OHCs (Supplementary Fig. 2b,e,f,g). The Prph(þ /þ )
OHCs typically had a single type II SGN bouton with a mean
volume of 1.20±0.10 mm3 (average of data from three blocks
from different mice), as well as three MOC efferent boutons
(mean volume¼ 14.22±0.83 mm3), consistent with data from
conventional transmission electron microscopy (TEM) analysis,
including discrimination of the efferent synapses by their size,
abundant mitochondria and typical presence of electron-dense
postsynaptic cisternae35. In the Prph( / ), the efferent
bouton number and distribution was comparable to the
Prph(þ /þ ) OHCs, with some hypertrophy (mean volume
19.05±0.95 mm3 (n¼ 3); P¼ 0.0186 (SA1)) (Supplementary
Fig. 2g; Supplementary Table 1).
Prph( / ) mice lack contralateral suppression. Baseline hear-
ing function was indistinguishable between the Prph( / ) and
Prph(þ /þ ) mice, as assessed using threshold and input–output
functions (ref. 36) for both auditory brainstem responses (ABR)
and cubic (2f1–f2) DPOAEs (Fig. 2).
The functional effect of Prph gene deletion on contralateral-
evoked MOC suppression was investigated using quadratic (f2–f1)
DPOAEs, a measure of cochlear amplifier gain that is modulated
by MOC efferent drive5. The contralateral suppression protocol
was initially optimized for Prph(þ /þ ) mice (Supplementary
Fig. 3) and three separate trials were then performed using a
range of stimuli delivered to the contralateral ear, with DPOAEs
recorded from the ipsilateral ear. Prph(þ /þ ), Prph(þ / ) and
Prph( / ) littermates from heterozygous breeding pairs were
used in a masked study with post-measurement genotyping. Two
unmasked studies utilized homozygous Prph( / ) mice, with
age- and sex-matched wild types from the background strain
(129Sv/C57BL/6). In the masked study, Prph(þ /þ ) mice (n¼ 8)
showed a mean reduction of the ipsilateral DPOAE amplitude of
3.2±1.1 dB in response to an 82 dB SPL 10–17 kHz contralateral
sound (60 s continuous) (Fig. 3a,b). This effect was evident from
the onset of the contralateral sound, with maximal suppression of
the OHC cochlear amplifier occurring within 5 s (Fig. 3a). The
suppression exhibited near-complete adaptation at 30 s sound
presentation. Heterozygous (Prph(þ / )) littermates showed
comparable contralateral suppression (2.6±0.4 dB, n¼ 25) with
adaptation. In contrast, Prph( / ) littermates exhibited a signi-
ficant lack of contralateral suppression, with no distinguishable
adaptation at the peak response time of the wild-type
and heterozygous mice (0.4±0.3 dB (n¼ 8); (Prph(þ /þ ) versus
Prph( / ) P¼ 0.007, Prph(þ / ) versus Prph( / ) P¼ 0.002
(SA2); Fig. 3a,b). The maximum residual reduction in
quadratic DPOAE with contralateral noise for Prph( / ) mice
occurred at B30 s (1.1±0.3 dB; P¼ 0.008 (SA3)), merging
with the residual adapting responses evident in the
Prph(þ /þ ) and Prph(þ / ) mice. Average starting f2–f1
DPOAE amplitudes were 29.4±1.5 dB (þ /þ ), 26.5±1.4 dB
(þ / ) and 18.0±2.7 dB ( / ).
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Figure 2 | Prph( / ) mice have baseline hearing indistinguishable from Prph(þ /þ ) littermate mice. (a,b) Cubic (2f1–f2) distortion product otoacoustic
emission (DPOAE) thresholds and 8 kHz input–output functions. (c,d) Auditory brainstem response (ABR) threshold and 8 kHz input–output functions for
the N1-P2 wave, which reflects cochlear nerve recruitment (n¼ 5). Data are shown as mean±s.e.m.; P40.05 (SA8).
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The first unmasked study used a shorter duration, more intense
and wider band contralateral sound exposure (96 dB SPL,
15–25 kHz) than that used for the masked study (Fig. 3c,d). For
these stimulus conditions, Prph(þ /þ ) mice showed greater
contralateral suppression (average over 15 s¼ 8.2±2.9 dB,
n¼ 7), with the peak suppression occurring B3 s after contral-
ateral noise onset. The Prph( / ) mice exhibited a slower rate of
change in their DPOAEs, with an average suppression of
1.5±0.4 dB (P¼ 0.0172 (SA4), n¼ 7). Adaptation of the
contralateral suppression was negligible with this duration of
contralateral sound (P¼ 0.011 (SA5) comparing the average of
the contralateral suppression in Prph( / ) and Prph(þ /þ )).
Baseline f2–f1 DPOAE amplitudes were 17.2±2.8 (þ /þ ) and
17.4±2.1 ( / ). This result was independently replicated in a
second unmasked study, where contralateral noise duration was
varied (5 to 30 s) to probe the absence of rapid-onset contralateral
suppression in the Prph( / ) mice (Supplementary Fig. 4).
These three independent experiments demonstrated that
Prph( / ) mice lack the MOC-mediated contralateral
suppression observed in wild types.
We validated our contralateral suppression model in two
control studies: acoustic cross-talk between cochleae was excluded
by physically disrupting the contralateral tympanic membrane
and ossicles (contralateral suppression 5.5±0.9 dB before versus
0.2±0.2 dB after; P¼ 0.004 (SA6), n¼ 3; 30 s 82 dB SPL
10–17 kHz noise; primaries at 65 dB SPL B28 kHz). To confirm
that the MOC efferent pathway was involved (and eliminate a
role for the middle ear muscle reflex, which drives the ossicular
chain tensor tympani and stapedius muscles, increasing middle
ear impedance and reducing sound transmission during loud
sound and vocalization37), we made a rostral–caudal incision at
the floor of the fourth ventricle (Supplementary Fig. 5,
contralateral suppression 3.9±0.6 dB before versus 1.2±0.3 dB
post section, P¼ 0.043 (SA6), n¼ 3; ref. 7).
Prph( / ) mice lack ipsilateral suppression. Ipsilateral
suppression is stronger than contralateral suppression, but more
challenging to quantify because the sound used to elicit the
MOC reflex is delivered over both the primary tones and the
DPOAEs13. We established a mouse model for ipsilateral
suppression of the cochlear amplifier by measuring the recovery
from a brief ipsilateral noise during on-going quadratic DPOAE
measurement.
MOC-recruiting ipsilateral sound stimulation (82 dB SPL,
10–25 kHz, 5 s) was presented over the DPOAE primary tones
(60 dB SPL, around 20 kHz). Immediately after the suppressor
noise ended, DPOAE measurements were restored and a
pronounced reduction in quadratic DPOAE was evident in
Prph(þ /þ ) and Prph(þ / ) mice. This ipsilateral suppression
adapted within B10 s, to a sustained offset from the pre-noise
intensity (immediate DPOAE intensity reduction 9.7±2 dB;
average DPOAE reduction at 21 to 45 s post noise 4±1.4 dB;
P¼ 0.004 (SA3); n¼ 9; Fig. 4a). These results contrasted with a
smaller immediate DPOAE reduction post noise (5.0±1.9 dB) in
the Prph( / ) mice, that very rapidly (B10 s) returned to
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Figure 3 | Prph( / ) mice lack contralateral suppression. (a,b) Contralateral suppression was observed as a significant reduction in the amplitude of the
ipsilateral f2–f1 DPOAE (65 dB about 28 kHz) in Prph
(þ /þ ) and Prph(þ / ) littermates in response to 82 dB 10–17 kHz contralateral sound (60 s). In
contrast, rapid contralateral suppression was absent in Prph( / ) littermate mice (**P¼0.007 Prph(þ /þ ) versus Prph( / ), P¼0.002 Prph(þ / )
versus Prph( / ), (SA9); n¼8 for (þ /þ ) and ( / ), n¼ 25 for (þ / )). Data in b are from the first measurement after noise onset relative to the
average of the pre-noise baseline. (c,d) In a separate set of experiments with contralateral suppressor 96 dB 15–25 kHz and 60dB about 20 kHz for the
DPOAE driver, Prph(þ /þ ) mice had higher rapid-onset suppression, whereas the Prph( / ) mice showed a small response with slow kinetics (**P¼0.011
(SA5), n¼ 7 for each). Data in d are the average of the nine measurements during the 15 s contralateral noise, relative to the average of the pre-noise
baseline. Insets in a and c show example recordings. Box plots in b and d have boundaries indicating 25th and 75th percentile, solid line is median, dashed
line is mean, with individual data overlaid; error bars indicate 95% confidence limits. For a and c, data are shown as mean±s.e.m.
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baseline (1.4±1.7 dB; n¼ 6; P¼ 0.461 (SA4); Fig. 4a). Average
starting f2–f1 DPOAE amplitudes were 15.5±2.0 dB (þ /þ )/
(þ / ) and 10.3±0.8 dB ( / ). The role of the ipsilateral
MOC reflex in this response was confirmed by section of the
MOC pathway at the floor of the fourth ventricle in Prph(þ /þ )
and Prph(þ / ) mice (Fig. 4a inset; n¼ 3). This showed that the
immediate post noise reduction in DPOAE was reduced to that
seen in the Prph( / ) mice, and the measurements from
B9 s post noise similarly returned to baseline. Thus ipsilateral
suppression without the MOC contribution in Prph(þ /þ )
mice was indistinguishable from that observed in Prph( / )
mice with an intact MOC fibre tract.
In a second set of experiments with a different group of mice,
30 s of 82 dB SPL, 15–25 kHz ipsilateral sound was presented to
drive ipsilateral suppression (Fig. 4b). In Prph(þ /þ )and Prph(þ / )
mice, the magnitude of the off-noise transient reduction in the
quadratic DPOAE was comparable to that seen after 5 s of
ipsilateral stimulation (immediate reduction 10.6±1.5 dB; average
DPOAE reduction at 21 to 45 s post noise 5.1±1.4 dB). Again, no
sustained modulation was seen in the Prph( / ) mice (immediate
reduction 4.4±1.6 dB; average DPOAE reduction at 21 to 45 s post
noise 0.7±0.9 dB; P¼ 0.032 (SA7), 21 to 45 s post noise; n¼ 17 for
(þ /þ )/(þ / ), n¼ 6 for ( / )). Average starting f2–f1
DPOAE amplitudes before noise were 17.5±1.0 dB (þ /þ )/
(þ / ) and 15.2±1.6 dB ( / ). These data were used to extract
the efferent response from the immediate off-noise transient
(Prph(þ /þ )/(þ / ) minus Prph( / ) indicated as ‘WT/Het—
KO’, Fig. 4b inset), which remains after cutting the MOC tract in
WT mice (Fig. 4a inset). The latter is likely to reflect transient noise-
induced changes in electrochemical driving force38. This analysis
revealed MOC-mediated ipsilateral suppression, which adapted
over B21 s to a residual offset that lasted for several minutes
(see data after breaks in Fig. 4b showing recovery).
Discussion
Our findings determine that the OHC—type II SGN sensory
pathway drives the MOC efferent reflex-mediated control of the
cochlear amplifier. Thus, not only does sound transduction by
OHCs produce the electromotility that is the substrate of the
cochlear amplifier, but integration of OHC transduction at the
type II SGN afferent synapses provides the sensory coding of
cochlear amplifier gain that drives the negative feedback control
via the MOC efferent innervation to both cochleae (evident as
contralateral (Fig. 5a) and ipsilateral (Fig. 5b) suppression).
No functional contribution to hearing has previously been
established for type II SGN8,25; although central projections
to the cochlear nuclei alongside the type I SGN have been
documented25,39. Type II SGN excitability has been demonstrated
in vivo by cochlear electrical stimulation40, and their membrane
properties demonstrated in vitro22–24. Significantly, type II SGN
make multiple en passant synapses across multiple rows of OHCs
approximately a quarter of an octave basal to the corresponding
innervation of IHC by the type I SGN radial fibres8,25.
This is consistent with the coding of the active region of the
cochlear amplifier relative to the tonotopic coding by the
corresponding IHC8. The match of the type II SGN OHC
innervation to the MOC efferent regulation of the OHC-
controlled cochlear biomechanics was originally highlighted by
Kim20. The concept has also been supported by the recent
electrophysiological evidence from isolated rat organ of Corti,
showing integration of synaptic input from multiple OHCs
by type II SGN26.
The role of type II SGN fibres in conveying the operational
state of the cochlear amplifier to the MOC neurons is also
compatible with the known central projections of these fibres to
the cochlear nuclei. The type II SGN input overlaps extensively
with the type I SGN projections in the dorsal and ventral nuclei,
as well as having differential input to the granule cell region
(reviewed by Nayagam et al.25). Transneuronal retrograde
labelling via pseudorabies virus injections into the cochlea
indicate that the cochlear sensory drive to the MOC efferent
neurons within the superior olivary complex is most likely relayed
through planar multipolar cells of the posterior and anterior
ventral cochlear nuclei41, which overlaps with the type II SGN
projection.
The quadratic DPOAE contralateral suppression adaptation
profile, which takes tens of seconds, is consistent with slow
adaptation of MOC efferent-mediated inhibition of the cochlear
amplifier downstream of the OHC a9/a10 nAChRs42–44. Our
Prph( / ) model has also enabled the isolation of the sensory
drive for MOC efferent suppression arising from ipsilateral
sound. These data show that the ipsilateral suppression is
substantially stronger than the contralateral suppression for the
same input intensity, and adapts more slowly than the
contralateral suppression. This is evident from the sustained
B5 dB suppression after 30 s of ipsilateral noise (82 dB SPL;
Fig. 4b,b inset) compared with o1 dB residual suppression after
30 s contralateral noise (82 dB SPL; Fig. 3a). Consequently, the
rapid adaptation of contralateral suppression likely reflects
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Figure 4 | Prph( / ) mice lack ipsilateral suppression. (a) 5 s of 82 dB SPL 10–25 kHz ipsilateral suppressor sound produced a sustained reduction in the
amplitude of the ipsilateral f2–f1 DPOAE (60 dB SPL B20 kHz) in Prph(þ /þ ) and Prph(þ / ) mice (**P¼0.004 (SA3), 21–45 s post noise (lower bar,
comparing mean values); n¼9). In contrast, Prph( / ) mice had only a small transient modulation (upper bar; P¼0.461 (SA4); n¼6). Inset in a is a
control experiment in Prph(þ /þ ) mice that confirmed the involvement of the MOC reflex by sectioning the olivocochlear bundle at the floor of the fourth
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ipsilateral adaptation of the sensory coding from the cochlear
amplifier via the OHC—type II SGN in the (contralateral) cochlea
receiving the noise probe, rather than adaptation of the
downstream MOC efferent output to the opposite cochlea.
Hence, the sensory drive for contralateral suppression
attenuates rapidly. The dominance of ipsilateral suppression is
correlated with the bias in neural connectivity from the ipsilateral
cochlear nuclei to the MOC neurons on the opposite side of the
brainstem41. The discrimination between ipsilateral and
contralateral suppression properties achieved here by isolating
the type II fibre sensory driver has considerable significance for
understanding the weighting and differential adaptation of the
gain control of the cochlear amplifiers in each ear, and is likely to
have bearing on the design of cochlear implant systems for
binaural implantation.
Our study is also informative with regard to the role of the
intermediate filament PRPH, in sustaining neural connectivity.
Several studies have demonstrated its action in other neural
populations, including the finding that a subpopulation of
unmyelinated dorsal root ganglion sensory neurons was absent
in the Prph( / ) mouse31.
Atrophy of peripheral neurites in the type II SGN OSB fibres
was nearly complete in the Prph( / ) mice. This is likely due to
loss of PRPH-dependent neurite extension and stabilization
cues33 in the critical postnatal period for establishment of the
cochlear afferent innervation25,27,29. In this regard, the mouse
model provided a fortuitous advantage, as Prph expression by
SGN is constrained to the type II fibres from around E18 in the
mouse, which precedes the afferent innervation of the hair
cells27,29,30. In the rat, Prph expression is sustained in the type I
SGN over the early critical afferent innervation period34,45. It has
not been established whether mouse type I SGN fibres express
Prph at earlier embryonic periods, but the normality of the ABR
function in the Prph( / ) mice indicates that, even if this is the
case, it has not affected the establishment of the central auditory
circuitry, making it unlikely that an indirect action on type I
fibres is a factor in the loss of the MOC reflex suppression of
outer hair cell electromotility evident in these mice. Peripherin
expression in the adult mouse brainstem is highly constrained
and, outside of the central projections of the type II SGN, is not
correlated with the MOC reflex pathway46.
The elimination of the type II afferent boutons may also have
effects on the local neural circuitry within the organ of Corti, as
some interconnectivity between type II afferent fibres, MOC
efferent varicosities and inner hair cells has been identified47. The
hypertrophy of the MOC efferent boutons at the base of the
OHCs in the Prph( / ) mice is consistent with the reduction in
sensory drive48 to the central MOC efferent reflex circuit, evident
as a loss of dynamic suppression of the DPOAEs when sound is
presented to the ears.
Our data are consistent with the concept that the binaural
regulation of hearing sensitivity via the MOC efferent fibre-
mediated suppression of cochlear amplifier gain is largely an
autonomous reflex that utilizes a putative non-perceptive
auditory coding channel provided by the OHCs and type II
SGNs. This complements the lateral superior olivary complex
efferent fibres, which directly regulate the type I SGN output
via presynaptic termination beneath the IHCs12,49. The integrated
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Figure 5 | Schematic of the sensorimotor reflex pathways for contralateral and ipsilateral suppression of the cochlear amplifier that provides
dynamic control of the sensitivity and frequency selectivity of hearing. The schematic includes the outer hair cell (OHC)—type II spiral ganglion (SGN)
sensory input described here, with the previously established medial olivocochlear (MOC) efferent reflex pathway (derived from refs 21,54,55; note that in
the mouse, B75% of the medial olivocochlear (MOC) efferent fibres are within the crossed olivocochlear bundle (COCB; reviewed by ref. 56).
(a) Contralateral suppression: sound in one ear causes a reduction in distortion product otoacoustic emissions (DPOAE) in the opposite ear, reflecting a
reduction in the gain of the OHC-based cochlear amplifier. Type II spiral ganglion neuron (SGN) afferent fibres (green line) project to the cochlear nuclei
(CN). A relay neuron pathway (blue dashes) then drives the MOC neurons located in the superior olivary complex on both sides of the brainstem. These
MOC neurons project axons via crossed and uncrossed (UOCB) tracts (red dots) that approach the floor of the fourth ventricle (4V), before joining the
cochlear/vestibular nerve. These MOC efferent fibres terminate as cholinergic boutons at the base of the OHCs. In contrast, the sensory innervation
of the inner hair cells (IHC) by the type I SGN, which drive hearing perception, do not contribute to this reflex regulation of the cochlear amplifier.
(b) Ipsilateral suppression: noise in one ear can suppress the DPOAE in the same ear via the OHC—type II SGN—MOC reflex pathway.
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encoding of OHC transduction that underpins the cochlear
amplifier state, provides the sensory drive to adjust gain between
the two ears. This is evidently critical for balanced hearing, which
enables optimal sound localization16 and speech discrimination
in noise14,15,50. The MOC efferent pathway has also been
implicated in protection from hearing loss from sustained
noise17. Given that type II SGN loss is prevalent with aging51,
degradation of the OHC/type II SGN drive to MOC efferent-
based suppression of the cochlear amplifier may contribute to the
decline in hearing performance in noise with aging, and to age-
related hearing loss.
Methods
Animals. Male and female adult CBA/129 wild-type, 129Sv/C57BL/6 wild-type and
Prph( / ) mice on a 129Sv/C57BL/6 background were used for this study. The
Prph( / ) mouse model was established in 2001 using 129Sv strain embryonic
stem cells bearing the peripherin knockout construct (exon 1 deletion) that were
injected into C57BL/6 strain blastocysts. The chimeric mice were then crossed with
C57BL/6 mice to produce heterozygous peripherin KO mice31. In masked studies,
heterozygous breeders were used to provide littermates of identical genetic
background. PCR-based genotyping utilized the following primer sets: Prph-50-
UTR-F: 50-GCTCCTTGCCACCCGGCCTAGTTC-30 ; Prph-exon1-R: 50-AGGGC
TGCGTTCTGCTGCTC-30 ; Neo-F: 50-TTCGGCTATGACTGGGCACAACAG-30 ;
Neo-R: 50-TACTTTCTCGGCAGGAGCAAGGTG-30 . Immunolabelling with a
peripherin antibody (see Immunohistochemistry—below) validated the loss of
peripherin protein in the Prph( / ) mice. Experiments were conducted according
to UNSW Australia Animal Care and Ethics Committee guidelines.
Hearing function tests. Mice were anaesthetized using a ketamine cocktail con-
taining ketamine (40mg kg 1), xylazine (8mg kg 1) and acepromazine
(0.5mg kg 1) via intraperitoneal injections. Hearing testing was carried out using
an auditory-evoked potential and DPOAE workstation (TDT system 3 with RX6
and RX6–2 signal processors, Tucker Davis Technologies, Ft Lauderdale, FL, USA)
with BioSig32 software. Sound levels were calibrated using a one-quarter-inch Free
Field Measure Calibration Microphone (model 7016; ACO). Hearing testing was
carried out in a sound-attenuating chamber (Sonora Technology, Japan). The level
of anaesthesia (indicated by heart rate and breathing rate) was monitored using a
mouse oximetry system (MouseOx, STARR Life Sciences) and depth of anaesthesia
was further assessed by lack of tail-pinch response. The core body temperature of
the mice was clamped at 37 C by feedback control of a heating pad (Right Temp,
Able Scientific).
DPOAE: The right external auditory meatus of each mouse was coupled to a
small microphone used to detect changes in sound pressure which represent
DPOAEs (Etymotic ERB10þ , Etymotic Research). Two EC1 electrostatic speakers,
controlled by the Tucker Davis Technologies (TDT) system (BioSigRP software),
generated equal intensity primary tones (f1 and f2; f2/f1 ratio: 1.25). Recordings
were taken at 8, 12, 16 and 24 kHz presented from 0 to 70 dB SPL (increasing in
5 dB steps). Fifty measurements at 6.7 per second were averaged for each stimulus
intensity and frequency, which were analysed by Fast Fourier transformation.
Thresholds at the different frequencies were determined based on when the cubic
(2f1–f2) distortion product reached 5 dB above the noise floor, as the tone intensity
increased.
ABRs were recorded using three platinum subdermal electrodes inserted
subcutaneously at the vertex (þ ), over the mastoid process ( ) and near the base
of the tail (ground). An EC1 speaker provided either click, or puretone pip (8, 16
and 24 kHz) stimuli at 10 per second, in descending 5 dB steps (starting at 70 to
80 dB SPL). Each trace studied is an average of up to 512 raw recordings at each
intensity and frequency. Thresholds at the different frequencies were determined as
the lowest intensity at which ABR waves could be observed.
MOC efferent-mediated suppression of DPOAE: Either the contralateral or
ipsilateral ear was exposed to broadband suppressor sound stimulation while
DPOAEs were elicited using primary tones in the ipsilateral ear. 10–50
measurements were averaged (6.7/s) for each recording. Baseline DPOAE
measurements were taken before and recovery was monitored following the
suppressor stimulus. The amplitude of the quadratic (f2–f1) distortion product
relative to the noise floor was then analysed before, during and after the noise
stimulation. Broadband noise was generated using a National Instruments A/D,
with custom software to create the noise. The output was amplified using an SA1
amplifier (TDT) and delivered closed-field via either an MF1 or FF1 speaker (TDT)
using a coupler.
Surgical disruption of MOC efferent activity. These were all carried out in adult
CBA/129mice under ketamine (40mg kg 1), xylazine (8mg kg 1) and acepro-
mazine (0.5mg kg 1) anaesthesia. The contralateral tympanic membrane and
ossicles were surgically disrupted. Sectioning of the MOC neurons: The con-
tralateral suppression was robust and repeatable after an hour under the ketamine/
xylazine/acepromazine anaesthesia. Subsequently the MOC efferent fibres beneath
the floor of the fourth ventricle were sectioned with a scalpel blade incision just
ipsilateral to the midline, achieved via a dorsal fenestration between C1 and the
foramen, with supplementary isoflurane anaesthesia.
Immunohistochemistry. Immunohistochemical labelling was carried out on fresh
tissue from unexposed animals. Mouse cochleae were fixed by scali perfusion of 4%
paraformaldehyde, decalcified for 14 days in 8% EDTA and then dissected for
surface mount preparation or cryoprotected using sucrose and OCT before being
cryosectioned at 50mm. Nonspecific binding was blocked with 10–15% normal
goat or donkey serum, 1% Triton X-100 in phosphate-buffered saline (PBS) for 1 h
at room temperature (RT) and sections were then transferred to the primary
antibody solution; Neurofilament 200 kDa (Sigma, rabbit, 1:5,000); peripherin
(EB12405, Everest Biotech, goat, 1:10,000); CtBP2 (BD Bioscience, mouse, 1:500);
vesicular acetylcholine transporter (VAChT; Phoenix, goat, 1:200) in 5–15%
normal goat or donkey serum, 0.1% Triton X-100 in PBS) overnight at RT. The
sections were washed in PBS and appropriate secondary antibody was applied
overnight RT (Molecular Probes, 1:500 anti-rabbit IgG AlexaFluor 594, anti-goat
IgG AlexaFluor 488, anti-mouse IgG AlexaFluor 488). Following a further PBS
wash, DAPI was applied for 5min at 1:5,000. Two final washes in PBS were carried
out before the tissue was mounted using Vectashield (Vector Laboratories) and
imaged on a Zeiss confocal microscope (Zeiss 710 NLO). Data were obtained from
1 to 3 organ of Corti z stacks (30 mm) analysed per animal.
SBF-SEM—tissue preparation. Perfusion fixed cochleae were processed for 3View
(Gatan) field emission scanning electron microscopy (FESEM, Zeiss Sigma) incor-
porating sequential en bloc staining. Fixation included perfusion, after flushing, with
1% paraformaldehyde, 3% glutaraldehyde in 0.1M sodium cacodylate buffer, with
0.1M sucrose, 10mM betaine, 2mM CaCl2 (CSBC buffer), pH 7.4 for 1–2h. Cochleae
were then dissected, small windows cut in the labyrinth wall and further perfusion
fixed in the above solution. With continual light agitation on a rotor, tissue was
subsequently processed through successive solutions of; CSBC buffer (3 5min), 3%
K3Fe(CN)6 in CSBC buffer, 1:1 with 4% OsO4 (1h, 4 C), CSBC buffer (3 5min),
1% tannic acid in CSBC buffer (1 h), CSBC buffer (3 5min), 0.1% thiocarbohy-
drazide (20min), MQ water (3 5min), 4% OsO4 (aqueous; 30min), MQ water
(3 5min), saturated uranyl acetate (aqueous; 4 C, 18h), MQ water (3 5min),
lead citrate (30min, 60 C), MQ water (3 5min) and dehydrated in an alcohol–
acetone series for subsequent embedding in Araldite 502.
Conventional TEM was used to identify tissue preparation quality, and the
outer hair cell region, with samples imaged at x1–40 k using a digital TEM camera
at 4 MP. Block faces were then trimmed to B50–80 mm2 to facilitate optimal
imaging for subsequent SBF-SEM (3View, Gatan). Serial 50 nm sections were cut
and block faces imaged through B50 mm of tissue per block. Blocks from three
mice per genotype were scanned. Serial section EM, along with the increased
electron density of the afferent boutons and evident synaptic vesicles and an
electron-dense postsynaptic cistern in the efferent boutons provided unequivocal
discrimination of the type II afferent boutons from the MOC efferent boutons.
Outer hair cells and their associated afferent and efferent synaptic boutons were
manually identified from their characteristic morphology, and segmented using
TrakEM2 (ref. 52), a plugin developed for ImageJ (NIH) and packaged in the FIJI
distribution53. Segmentation of multiple slices along the axial plane yielded three-
dimensional reconstructions on which volume measurements were made.
Statistical analysis. Data are expressed as population mean±s.e.m. Statistical
analysis was carried out in SigmaPlot (V. 11, Systat Software, Germany). Statistical
tests cited in the text are indicated in Table 1. Holm–Sidak post hoc analysis was
utilized for multiple pairwise comparisons within analysis of variance, providing a
correction for repeated testing to maintain the type I error rate (false positive).
Data were tested for normal data distribution and a rank transformation was
applied where required. Power calculations based on pilot experiments informed
experimental design.
Table 1 | Statistical tests.
Code Statistical procedure
SA1 Two-tailed t-test
SA2 One-way ANOVA
SA3 Single-sample signed rank test
SA4 Single-sample t-test (two tailed)
SA5 Mann–Whitney rank-sum test
SA6 One-way repeated measures ANOVA
SA7 Two-way repeated measures ANOVA on ranked data
SA8 Two-way repeated measures ANOVA
SA9 One-way ANOVA on ranked data
ANOVA, analysis of variance.
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